plastic Recalls

B Braun Medical Blood Administration Set Recall 2025 for 24,624 Units Worldwide

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall for 4,488 Units in 2025

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 122,232 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 5,952 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall Affects 41,976 Units Worldwide (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 7,008 IV Administration Sets for Infusomat Space Pumps (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall 11,832 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set 490245 Recalled for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical SAFELINE IV Sets Recalled for 46,250 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall Affects 286,400 Units Across Global Pumps (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Extension Set 490234 Recalled for 27,480 Units Over IV Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Anesthesia IV Set Recalled for Backflow Risk (10,536 Units) 2025

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalled 19,320 Anesthesia IV Sets for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 9,500 IV Administration Sets for Backflow and Occlusion Risk (2025 Recall)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical 490238 Extension Set Recalled for IV Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Blood Administration Set Recall 7,344 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

BBraun Medical Blood Administration Set Recall 5,448 Units (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Sets Recalled for Backflow Risk and Occlusion (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

BBMIs Infusomat IV Administration Set Recall, 63,192 Units Worldwide for Backflow and Occlusion Risk

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

Twin Sisters Creamery Whatcom Farmhouse Cheese Recalled for Potential Contamination (411 lbs, 2025)